Hideo Nagata

Title: Hideo Nagata: Innovator in Pharmaceutical Chemistry

Introduction

Hideo Nagata is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzofuro[3,2-c]quinoline compounds. His research focuses on developing compounds that have potential utility as treatments for various medical conditions.

Latest Patents

Hideo Nagata holds a patent for acylated benzofuro[3,2-c]quinoline compounds. This patent describes compounds of the general formula wherein each of R¹ and R² represents a group of the formula --OR³, with R³ being a carbamoyl group, an N-mono-alkylcarbamoyl group, an N,N-dialkylcarbamoyl group, an alkylsulfonyl group, a formyl group, or an aliphatic acyl group that may have an alkoxycarbonyl group as a substituent. The patent highlights the versatility of these compounds in medicinal applications.

Career Highlights

Hideo Nagata is associated with Kissei Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical products. His work has contributed to the company's reputation for innovation in drug development.

Collaborations

Hideo has collaborated with notable colleagues such as Tetsuhide Kamijo and Arao Ujiie. These collaborations have fostered a productive environment for research and innovation within the company.

Conclusion

Hideo Nagata's contributions to pharmaceutical chemistry, particularly through his patented innovations, underscore his role as a key figure in the field. His work continues to influence the development of new treatments, showcasing the importance of innovation in healthcare.